Oral Solid Dose Formulations

iDPC can tailor coatings to modulate dissolution performances either to enhance or delay drug release profiles to deliver a targeted profile, whilst enhancing stability and optimising form manufacture.


oral formulation

APT has extensive experience in solving complex formulation development challenges, our experts and proprietary iDPC technology can provide you the best solution to optimise drug delivery from pre-formulation up to clinical manufacturing

Oral Formulations

Oral formulations
oral dissolution profile
Enhanced dissolution of low soluble API through iDPC formulation development.
Screenshot 2023 01 24 1.04.28 PM Display 1
iDPC modulates and tailor API release profile through application of different coatings - deliver the desired dissolution profile.